Howell SB - Search Results

1

Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!

Alberts DS, Markman M, Armstrong D, Rothenberg ML, Muggia F, Howell SB. Alberts DS, et al. Among authors: howell sb. J Clin Oncol. 2002 Oct 1;20(19):3944-6. doi: 10.1200/JCO.2002.20.19.3944. J Clin Oncol. 2002. PMID: 12351590 No abstract available.

2

Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity.

Markman M, Cleary S, Lucas WE, Howell SB. Markman M, et al. Among authors: howell sb. J Clin Oncol. 1985 Jul;3(7):925-31. doi: 10.1200/JCO.1985.3.7.925. J Clin Oncol. 1985. PMID: 3894586 Clinical Trial.

3

Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity.

Markman M, Howell SB, Lucas WE, Pfeifle CE, Green MR. Markman M, et al. Among authors: howell sb. J Clin Oncol. 1984 Dec;2(12):1321-6. doi: 10.1200/JCO.1984.2.12.1321. J Clin Oncol. 1984. PMID: 6542584

4

Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients.

Samimi G, Varki NM, Wilczynski S, Safaei R, Alberts DS, Howell SB. Samimi G, et al. Among authors: howell sb. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5853-9. Clin Cancer Res. 2003. PMID: 14676106

5

Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.

Howell SB, Zimm S, Markman M, Abramson IS, Cleary S, Lucas WE, Weiss RJ. Howell SB, et al. J Clin Oncol. 1987 Oct;5(10):1607-12. doi: 10.1200/JCO.1987.5.10.1607. J Clin Oncol. 1987. PMID: 2443622

6

Totally implantable system for peritoneal access.

Pfeifle CE, Howell SB, Markman M, Lucas WE. Pfeifle CE, et al. Among authors: howell sb. J Clin Oncol. 1984 Nov;2(11):1277-80. doi: 10.1200/JCO.1984.2.11.1277. J Clin Oncol. 1984. PMID: 6491705

7

Hypomagnesemia following high-dose intracavitary cisplatin with systemically administered sodium thiosulfate.

Markman M, Cleary S, Howell SB. Markman M, et al. Among authors: howell sb. Am J Clin Oncol. 1986 Oct;9(5):440-3. doi: 10.1097/00000421-198610000-00016. Am J Clin Oncol. 1986. PMID: 3776908

8

Intraperitoneal chemotherapy for advanced ovarian cancer.

Lucas WE, Markman M, Howell SB. Lucas WE, et al. Among authors: howell sb. Am J Obstet Gynecol. 1985 Jun 15;152(4):474-8. doi: 10.1016/s0002-9378(85)80160-5. Am J Obstet Gynecol. 1985. PMID: 3925784

9

High-dose cisplatin with sodium thiosulfate protection.

Pfeifle CE, Howell SB, Felthouse RD, Woliver TB, Andrews PA, Markman M, Murphy MP. Pfeifle CE, et al. Among authors: howell sb. J Clin Oncol. 1985 Feb;3(2):237-44. doi: 10.1200/JCO.1985.3.2.237. J Clin Oncol. 1985. PMID: 4038510

10

Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.

Samimi G, Fink D, Varki NM, Husain A, Hoskins WJ, Alberts DS, Howell SB. Samimi G, et al. Among authors: howell sb. Clin Cancer Res. 2000 Apr;6(4):1415-21. Clin Cancer Res. 2000. PMID: 10778972

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters